These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 30728025)
1. Important advances in Alzheimer's disease from the use of induced pluripotent stem cells. Majolo F; Marinowic DR; Machado DC; Da Costa JC J Biomed Sci; 2019 Feb; 26(1):15. PubMed ID: 30728025 [TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy. Yang J; Li S; He XB; Cheng C; Le W Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028 [TBL] [Abstract][Full Text] [Related]
3. Protein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Aβ Deposition in a Mouse Model of Alzheimer's Disease. Cha MY; Kwon YW; Ahn HS; Jeong H; Lee YY; Moon M; Baik SH; Kim DK; Song H; Yi EC; Hwang D; Kim HS; Mook-Jung I Stem Cells Transl Med; 2017 Jan; 6(1):293-305. PubMed ID: 28170178 [TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks. Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079 [TBL] [Abstract][Full Text] [Related]
5. Advances in the Application of Induced Pluripotent Stem Cells in Alzheimer's Disease and Parkinson's Disease. Xu Y; Wang S; Zhu P Curr Stem Cell Res Ther; 2023; 18(2):154-162. PubMed ID: 35473516 [TBL] [Abstract][Full Text] [Related]
6. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases. Machairaki V Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463 [TBL] [Abstract][Full Text] [Related]
7. Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer's disease. Csöbönyeiová M; Polák Š; Danišovič L Rev Neurosci; 2016 Jul; 27(5):457-64. PubMed ID: 26812864 [TBL] [Abstract][Full Text] [Related]
8. Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling. Zhu D; Kong CSL; Gingold JA; Zhao R; Lee DF Adv Exp Med Biol; 2018; 1119():169-183. PubMed ID: 30069853 [TBL] [Abstract][Full Text] [Related]
9. Induced Pluripotent Stem Cell-Derived Astroglia: A New Tool for Research Towards the Treatment of Alzheimer's Disease. Atkinson-Dell R; Mohamet L Adv Exp Med Biol; 2019; 1175():383-405. PubMed ID: 31583596 [TBL] [Abstract][Full Text] [Related]
11. Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development. Karagiannis P; Takahashi K; Saito M; Yoshida Y; Okita K; Watanabe A; Inoue H; Yamashita JK; Todani M; Nakagawa M; Osawa M; Yashiro Y; Yamanaka S; Osafune K Physiol Rev; 2019 Jan; 99(1):79-114. PubMed ID: 30328784 [TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1. Tubsuwan A; Pires C; Rasmussen MA; Schmid B; Nielsen JE; Hjermind LE; Hall V; Nielsen TT; Waldemar G; Hyttel P; Clausen C; Kitiyanant N; Freude KK; Holst B Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792 [TBL] [Abstract][Full Text] [Related]
13. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases. Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228 [TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells as a discovery tool for Alzheimer׳s disease. Sullivan SE; Young-Pearse TL Brain Res; 2017 Feb; 1656():98-106. PubMed ID: 26459988 [TBL] [Abstract][Full Text] [Related]
15. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1. Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973 [TBL] [Abstract][Full Text] [Related]
16. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease. Marei HE; Khan MUA; Hasan A Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028 [TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1. Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Holst B; Hyttel P; Freude KK Stem Cell Res; 2016 Mar; 16(2):334-7. PubMed ID: 27345998 [TBL] [Abstract][Full Text] [Related]
18. Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer's disease. Riemens RJM; Kenis G; van den Beucken T Neurobiol Learn Mem; 2020 Nov; 175():107318. PubMed ID: 32977028 [TBL] [Abstract][Full Text] [Related]
19. Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells. Tsai PH; Chang YC; Lee YY; Ko YL; Yang YH; Lin CF; Chang YL; Yu WC; Shih YH; Chen MT J Chin Med Assoc; 2015 Jun; 78(6):353-9. PubMed ID: 26022695 [TBL] [Abstract][Full Text] [Related]
20. Establishment of TUSMi008-A, an induced pluripotent stem cell (iPSC) line from a 76-year old Alzheimer's disease (AD) patient with PAXIP1 gene mutation. Wang Y; Zhang J; Hu J; Li G; Lei Y; Zhao J Stem Cell Res; 2019 Apr; 36():101391. PubMed ID: 30831521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]